BASIC SCIENCE
Fibrosis of the left atria during progression of heart failure is associated with increased matrix metalloproteinases in the rat
Christophe Boixel, PhD*,
Vincent Fontaine, PhD*,
Catherine Rücker-Martin, PhD ,
Paul Milliez, MD ,
Liliane Louedec, MS*,
Jean-Baptiste Michel, MD, PhD*,
Marie-Paule Jacob, PhD* and
Stéphane N. Hatem, MD, PhD* ,*
* INSERM Unité 460, Paris, France
Centre dExploration Fonctionnelle Intégrée Hôpital Xavier Bichat, Paris, France
CNRS-UMR 8078, Hôpital Marie Lannelongue, 92350 Le Plessis Robinson, France
INSERM Unité 572, Hôpital Lariboisière, Paris, France
Manuscript received October 13, 2002;
revised manuscript received January 7, 2003,
accepted February 6, 2003.
* Reprint requests and correspondence: Dr. Stéphane Hatem, INSERM Unité 460, Faculté de Médecine Bichat-Claude Bernard, 46 rue Henri Huchard, 75018, Paris, France. hatem{at}bichat.inserm.fr
OBJECTIVES: The purpose of this study was to determine the pathogenic factors and molecular mechanisms involved in fibrosis of the atria.
BACKGROUND: Fibrosis is an important component of the pathophysiology of atrial fibrillation, especially when the arrhythmia is associated with heart failure (HF) or atrial dilation.
METHODS: We used a rat model of myocardial infarction (MI) complicated by various degrees of left ventricular dysfunction and atrial dilation to study fibrosis and matrix metalloproteinase (MMP) activity in the left atrial (LA) myocardium by means of histologic, Western blot, zymographic, and immunohistologic techniques.
RESULTS: Three months after surgical ligature of the left coronary artery, 27 rats had a large MI, 12 were in mild HF, and 15 in severe HF. Both groups had LA enlargement at the echocardiography. Massons trichrome and picrosirius staining of tissue sections revealed marked fibrosis at the periphery of trabeculae and also surrounding myolytic myocytes, in both mild and severe HF. In mild HF, the activity and expression of the matrilysin MMP-7 were increased (122%), whereas in severe HF, both MMP-7 (211%) and the gelatinase MMP-2 (187%) were up-regulated. There were no changes in the expression or activity of MMP inhibitors, TIMP-1, -2, and -4. Immunostaining of cryosections showed that MMP-2 was present in the interstitial spaces, whereas MMP-7 accumulated in myolytic myocytes.
CONCLUSIONS: Hemodynamic overload of the atria is an important pathogenic factor of fibrosis; MMP-7 appears to be involved in the early stage of this tissue remodeling process.
|
Abbreviations and Acronyms
| | AF | = atrial fibrillation | | ANP | = atrial natriuretic peptide | | AU | = arbitrary unit | | HF | = heart failure | | LA | = left atria/atrial | | LV | = left ventricle | | MI | = myocardial infarction | | MMP | = matrix metalloproteinase | | RA | = right atria/atrial | | TIMP | = tissue inhibitor of metalloproteinase |
|
This article has been cited by other articles:

|
 |

|
 |
 
M. Perez-Ilzarbe, O. Agbulut, B. Pelacho, C. Ciorba, E. S. Jose-Eneriz, M. Desnos, A. A. Hagege, P. Aranda, E. J. Andreu, P. Menasche, et al.
Characterization of the paracrine effects of human skeletal myoblasts transplanted in infarcted myocardium
Eur J Heart Fail,
November 1, 2008;
10(11):
1065 - 1072.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Casaclang-Verzosa, B. J. Gersh, and T. S.M. Tsang
Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation.
J. Am. Coll. Cardiol.,
January 1, 2008;
51(1):
1 - 11.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. N. Tziakas, G. K. Chalikias, N. Papanas, D. A. Stakos, S. V. Chatzikyriakou, and E. Maltezos
Circulating levels of collagen type I degradation marker depend on the type of atrial fibrillation
Europace,
August 1, 2007;
9(8):
589 - 596.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. W. Lee, T. H. Everett IV, D. Rahmutula, J. M. Guerra, E. Wilson, C. Ding, and J. E. Olgin
Pirfenidone Prevents the Development of a Vulnerable Substrate for Atrial Fibrillation in a Canine Model of Heart Failure
Circulation,
October 17, 2006;
114(16):
1703 - 1712.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Rucker-Martin, P. Milliez, S. Tan, X. Decrouy, M. Recouvreur, R. Vranckx, C. Delcayre, J.-F. Renaud, I. Dunia, D. Segretain, et al.
Chronic hemodynamic overload of the atria is an important factor for gap junction remodeling in human and rat hearts
Cardiovasc Res,
October 1, 2006;
72(1):
69 - 79.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Osranek, K. Fatema, F. Qaddoura, A. Al-Saileek, M. E. Barnes, K. R. Bailey, B. J. Gersh, T. S.M. Tsang, K. J. Zehr, and J. B. Seward
Left Atrial Volume Predicts the Risk of Atrial Fibrillation After Cardiac Surgery: A Prospective Study
J. Am. Coll. Cardiol.,
August 15, 2006;
48(4):
779 - 786.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Lindsey, G. P. Escobar, R. Mukherjee, D. K. Goshorn, N. J. Sheats, J. A. Bruce, I. M. Mains, J. K. Hendrick, K. W. Hewett, R. G. Gourdie, et al.
Matrix Metalloproteinase-7 Affects Connexin-43 Levels, Electrical Conduction, and Survival After Myocardial Infarction
Circulation,
June 27, 2006;
113(25):
2919 - 2928.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. A. Alsaileek, M. Osranek, K. Fatema, R. B. McCully, T. S. Tsang, and J. B. Seward
Predictive Value of Normal Left Atrial Volume in Stress Echocardiography
J. Am. Coll. Cardiol.,
March 7, 2006;
47(5):
1024 - 1028.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Osranek, F. Bursi, K. R. Bailey, B. R. Grossardt, R. D. Brown Jr, S. L. Kopecky, T. S. Tsang, and J. B. Seward
Left atrial volume predicts cardiovascular events in patients originally diagnosed with lone atrial fibrillation: three-decade follow-up
Eur. Heart J.,
December 1, 2005;
26(23):
2556 - 2561.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Shah, F. G. Akar, and G. F. Tomaselli
Molecular Basis of Arrhythmias
Circulation,
October 18, 2005;
112(16):
2517 - 2529.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Milliez, N. DeAngelis, C. Rucker-Martin, A. Leenhardt, E. Vicaut, E. Robidel, P. Beaufils, C. Delcayre, and S. N. Hatem
Spironolactone reduces fibrosis of dilated atria during heart failure in rats with myocardial infarction
Eur. Heart J.,
October 2, 2005;
26(20):
2193 - 2199.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Milliez, X. Girerd, P.-F. Plouin, J. Blacher, M. E. Safar, and J.-J. Mourad
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
J. Am. Coll. Cardiol.,
April 19, 2005;
45(8):
1243 - 1248.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Garcia, D. P. Pantazatos, C. R. Gessner, K. V. Go, V. L. Woods Jr., and F. J. Villarreal
Molecular Interactions between Matrilysin and the Matrix Metalloproteinase Inhibitor Doxycycline Investigated by Deuterium Exchange Mass Spectrometry
Mol. Pharmacol.,
April 1, 2005;
67(4):
1128 - 1136.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Polyakova, S. Hein, S. Kostin, T. Ziegelhoeffer, and J. Schaper
Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression
J. Am. Coll. Cardiol.,
October 19, 2004;
44(8):
1609 - 1618.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Goette and U. Lendeckel
Tachycardia-induced remodeling: atria and ventricles take a different route
Cardiovasc Res,
August 1, 2004;
63(2):
194 - 195.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Hanna, S. Cardin, T.-K. Leung, and S. Nattel
Differences in atrial versus ventricular remodeling in dogs with ventricular tachypacing-induced congestive heart failure
Cardiovasc Res,
August 1, 2004;
63(2):
236 - 244.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J.S. Laffin, T. E. Scheetz, M. de Fatima Bonaldo, R. S. Reiter, S. Chang, M. Eyestone, H. Abdulkawy, B. Brown, C. Roberts, D. Tack, et al.
A comprehensive nonredundant expressed sequence tag collection for the developing Rattus norvegicus heart
Physiol Genomics,
April 13, 2004;
17(2):
245 - 252.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Marin, V. Roldan, V. Climent, and G. Y. H. Lip
Matrix metalloproteinases in atrial fibrillation
J. Am. Coll. Cardiol.,
January 7, 2004;
43(1):
152 - 152.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Boixel, V. Fontaine, J.-B. Michel, M.-P. Jacob, and S. Hatem
Matrix metalloproteinases in atrial fibrillation: Reply
J. Am. Coll. Cardiol.,
January 7, 2004;
43(1):
152 - 153.
[Full Text]
[PDF]
|
 |
|
|